John Hussman's PRAX Position Overview
John Hussman (via Hussman Strategic Advisors, Inc.) currently holds 8,400 shares of Praxis Precision Medicines, Inc. (PRAX) worth $2.48 M, representing 0.60% of the portfolio. First purchased in 2024-Q2, this short-term holding has been held for 7 quarters.
Based on 13F filings, John Hussman has maintained this position in PRAX for several quarters, showing initial confidence in the investment. Largest reduction occurred in Q4 2024, reducing 10,500 shares.
Analysis based on 13F filings available since 2013 Q2
John Hussman's Praxis Precision Medicines (PRAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Praxis Precision Medicines (PRAX) Trades by John Hussman
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -2,100 | Reduce 20.00% | 8,400 | $294.74 |
| Q4 2024 | -10,500 | Reduce 50.00% | 10,500 | $76.96 |
| Q2 2024 | +21,000 | New Buy | 21,000 | $41.36 |
John Hussman's Praxis Precision Medicines Investment FAQs
John Hussman first purchased Praxis Precision Medicines, Inc. (PRAX) in Q2 2024, acquiring 21,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
John Hussman has held Praxis Precision Medicines, Inc. (PRAX) for 7 quarters since Q2 2024.
John Hussman's largest addition to Praxis Precision Medicines, Inc. (PRAX) was in Q2 2024, adding 21,000 shares worth $868,560.
According to the latest 13F filing for Q4 2025, John Hussman's firm, Hussman Strategic Advisors, Inc., owns 8,400 shares of Praxis Precision Medicines, Inc. (PRAX), valued at approximately $2.48 M.
As of the Q4 2025 filing, Praxis Precision Medicines, Inc. (PRAX) represents approximately 0.60% of John Hussman's publicly disclosed stock portfolio, making it one of their key holdings.
John Hussman's peak holding in Praxis Precision Medicines, Inc. (PRAX) was 21,000 shares, as reported at the end of Q2 2024.